Cargando…
Invasive papillary carcinoma treated with neoadjuvant endocrine therapy in which pathological complete response was achieved
BACKGROUND: Invasive papillary carcinoma is a rare type of invasive ductal carcinoma. Neoadjuvant endocrine therapy is now considered as an optional therapy for postmenopausal women with hormone receptor-positive breast cancers, including invasive papillary carcinoma. CASE PRESENTATION: We discuss t...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727271/ https://www.ncbi.nlm.nih.gov/pubmed/26813772 http://dx.doi.org/10.1186/s13104-016-1854-4 |
_version_ | 1782411935493390336 |
---|---|
author | Saita, Chiaki Goto, Risa Aruga, Tomoyuki Idera, Nami Honda, Yayoi Horiguchi, Kazumi Miyamoto, Hiromi Horiguchi, Shinichiro Yamashita, Toshinari Kuroi, Katsumasa |
author_facet | Saita, Chiaki Goto, Risa Aruga, Tomoyuki Idera, Nami Honda, Yayoi Horiguchi, Kazumi Miyamoto, Hiromi Horiguchi, Shinichiro Yamashita, Toshinari Kuroi, Katsumasa |
author_sort | Saita, Chiaki |
collection | PubMed |
description | BACKGROUND: Invasive papillary carcinoma is a rare type of invasive ductal carcinoma. Neoadjuvant endocrine therapy is now considered as an optional therapy for postmenopausal women with hormone receptor-positive breast cancers, including invasive papillary carcinoma. CASE PRESENTATION: We discuss the case of an 83-year-old postmenopausal Japanese female with hormone receptor-positive invasive papillary carcinoma who started treatment with an aromatase inhibitor and achieved pathological complete response after 12 months of endocrine treatment. CONCLUSION: Appropriate drugs and durations of neoadjuvant endocrine treatment have yet to be established. Continuing therapy with an aromatase inhibitor until the best clinical response is achieved may represent one of the best strategies in neoadjuvant endocrine therapy. |
format | Online Article Text |
id | pubmed-4727271 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47272712016-01-27 Invasive papillary carcinoma treated with neoadjuvant endocrine therapy in which pathological complete response was achieved Saita, Chiaki Goto, Risa Aruga, Tomoyuki Idera, Nami Honda, Yayoi Horiguchi, Kazumi Miyamoto, Hiromi Horiguchi, Shinichiro Yamashita, Toshinari Kuroi, Katsumasa BMC Res Notes Case Report BACKGROUND: Invasive papillary carcinoma is a rare type of invasive ductal carcinoma. Neoadjuvant endocrine therapy is now considered as an optional therapy for postmenopausal women with hormone receptor-positive breast cancers, including invasive papillary carcinoma. CASE PRESENTATION: We discuss the case of an 83-year-old postmenopausal Japanese female with hormone receptor-positive invasive papillary carcinoma who started treatment with an aromatase inhibitor and achieved pathological complete response after 12 months of endocrine treatment. CONCLUSION: Appropriate drugs and durations of neoadjuvant endocrine treatment have yet to be established. Continuing therapy with an aromatase inhibitor until the best clinical response is achieved may represent one of the best strategies in neoadjuvant endocrine therapy. BioMed Central 2016-01-26 /pmc/articles/PMC4727271/ /pubmed/26813772 http://dx.doi.org/10.1186/s13104-016-1854-4 Text en © Saita et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Saita, Chiaki Goto, Risa Aruga, Tomoyuki Idera, Nami Honda, Yayoi Horiguchi, Kazumi Miyamoto, Hiromi Horiguchi, Shinichiro Yamashita, Toshinari Kuroi, Katsumasa Invasive papillary carcinoma treated with neoadjuvant endocrine therapy in which pathological complete response was achieved |
title | Invasive papillary carcinoma treated with neoadjuvant endocrine therapy in which pathological complete response was achieved |
title_full | Invasive papillary carcinoma treated with neoadjuvant endocrine therapy in which pathological complete response was achieved |
title_fullStr | Invasive papillary carcinoma treated with neoadjuvant endocrine therapy in which pathological complete response was achieved |
title_full_unstemmed | Invasive papillary carcinoma treated with neoadjuvant endocrine therapy in which pathological complete response was achieved |
title_short | Invasive papillary carcinoma treated with neoadjuvant endocrine therapy in which pathological complete response was achieved |
title_sort | invasive papillary carcinoma treated with neoadjuvant endocrine therapy in which pathological complete response was achieved |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727271/ https://www.ncbi.nlm.nih.gov/pubmed/26813772 http://dx.doi.org/10.1186/s13104-016-1854-4 |
work_keys_str_mv | AT saitachiaki invasivepapillarycarcinomatreatedwithneoadjuvantendocrinetherapyinwhichpathologicalcompleteresponsewasachieved AT gotorisa invasivepapillarycarcinomatreatedwithneoadjuvantendocrinetherapyinwhichpathologicalcompleteresponsewasachieved AT arugatomoyuki invasivepapillarycarcinomatreatedwithneoadjuvantendocrinetherapyinwhichpathologicalcompleteresponsewasachieved AT ideranami invasivepapillarycarcinomatreatedwithneoadjuvantendocrinetherapyinwhichpathologicalcompleteresponsewasachieved AT hondayayoi invasivepapillarycarcinomatreatedwithneoadjuvantendocrinetherapyinwhichpathologicalcompleteresponsewasachieved AT horiguchikazumi invasivepapillarycarcinomatreatedwithneoadjuvantendocrinetherapyinwhichpathologicalcompleteresponsewasachieved AT miyamotohiromi invasivepapillarycarcinomatreatedwithneoadjuvantendocrinetherapyinwhichpathologicalcompleteresponsewasachieved AT horiguchishinichiro invasivepapillarycarcinomatreatedwithneoadjuvantendocrinetherapyinwhichpathologicalcompleteresponsewasachieved AT yamashitatoshinari invasivepapillarycarcinomatreatedwithneoadjuvantendocrinetherapyinwhichpathologicalcompleteresponsewasachieved AT kuroikatsumasa invasivepapillarycarcinomatreatedwithneoadjuvantendocrinetherapyinwhichpathologicalcompleteresponsewasachieved |